134 related articles for article (PubMed ID: 30481863)
1. [Clinical significance of epidermal growth factor receptor and thymidylate synthase expression in primary liver cancer].
Guo FY; Yang J; Xiong SM; Zhu MQ; Gao S; Li JP
Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):666-669. PubMed ID: 30481863
[No Abstract] [Full Text] [Related]
2. Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer.
Dorff TB; Schuckman AK; Schwartz R; Rashad S; Bulbul A; Cai J; Pinski J; Ma Y; Danenberg K; Skinner E; Quinn DI
Clin Genitourin Cancer; 2016 Oct; 14(5):450-456.e1. PubMed ID: 26935231
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Prognostic Value of ERCC1 and Thymidylate Synthase Expression and the Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma Non-Small-Cell Lung Cancer.
Lin CS; Liu TC; Lai JC; Yang SF; Tsao TC
Int J Med Sci; 2017; 14(13):1410-1417. PubMed ID: 29200955
[TBL] [Abstract][Full Text] [Related]
4. High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma.
Donner DB; Nakakura EK; Venook AP; Lenz HJ; Zhang W; Hwang J; Bergsland EK; Lin MH; Toriguchi K; Antonia RJ; Warren RS
PLoS One; 2019; 14(7):e0219469. PubMed ID: 31291332
[TBL] [Abstract][Full Text] [Related]
5. A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803.
Niedzwiecki D; Hasson RM; Lenz HJ; Ye C; Redston M; Ogino S; Fuchs CS; Compton CC; Mayer RJ; Goldberg RM; Colacchio TA; Saltz LB; Warren RS; Bertagnolli MM
Oncologist; 2017 Jan; 22(1):107-114. PubMed ID: 27821793
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of thymidylate synthase (TS) expression in cutaneous malignant melanoma.
Shimizu A; Kaira K; Yasuda M; Asao T; Ishikawa O
Neoplasma; 2016; 63(2):282-7. PubMed ID: 26774151
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer.
Gonen M; Hummer A; Zervoudakis A; Sullivan D; Fong Y; Banerjee D; Klimstra D; Cordon-Cardo C; Bertino J; Kemeny N
J Clin Oncol; 2003 Feb; 21(3):406-12. PubMed ID: 12560427
[TBL] [Abstract][Full Text] [Related]
8. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
[TBL] [Abstract][Full Text] [Related]
9. ERCC1 and TS Expression as Prognostic and Predictive Biomarkers in Metastatic Colon Cancer.
Choueiri MB; Shen JP; Gross AM; Huang JK; Ideker T; Fanta P
PLoS One; 2015; 10(6):e0126898. PubMed ID: 26083491
[TBL] [Abstract][Full Text] [Related]
10. Predictive Significance of Thymidylate Synthase Expression in Non-small Cell Lung Cancer.
Kulda V; Hrda K; Houdek Z; Dobra JK; Vrzakova R; Svaton M; Safranek J; Dolezal J; Babuska V; Pesek M; Topolcan O; Pesta M
Anticancer Res; 2017 Dec; 37(12):6953-6958. PubMed ID: 29187479
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of thymidylate synthase expression in bladder cancer.
Nomura T; Nakagawa M; Fujita Y; Hanada T; Mimata H; Nomura Y
Int J Urol; 2002 Jul; 9(7):368-76. PubMed ID: 12165018
[TBL] [Abstract][Full Text] [Related]
12. Expression of thymidylate synthase (TS) and its prognostic significance in patients with cutaneous angiosarcoma.
Shimizu A; Kaira K; Okubo Y; Utsumi D; Bolag A; Yasuda M; Takahashi K; Ishikawa O
Neoplasma; 2017; 64(6):916-921. PubMed ID: 28895418
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.
Goos JA; Hiemstra AC; Coupé VM; Diosdado B; Kooijman W; Delis-Van Diemen PM; Karga C; Beliën JA; Menke-van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ; ;
Br J Cancer; 2014 Aug; 111(4):749-55. PubMed ID: 24983372
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
Christensen A; Kiss K; Lelkaitis G; Juhl K; Persson M; Charabi BW; Mortensen J; Forman JL; Sørensen AL; Jensen DH; Kjaer A; von Buchwald C
BMC Cancer; 2017 Aug; 17(1):572. PubMed ID: 28841839
[TBL] [Abstract][Full Text] [Related]
15. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
16. Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival.
Lee HS; Chen M; Kim JH; Kim WH; Ahn S; Maeng K; Allegra CJ; Kaye FJ; Hochwald SN; Zajac-Kaye M
Int J Cancer; 2014 Jul; 135(1):128-37. PubMed ID: 24347111
[TBL] [Abstract][Full Text] [Related]
17. Immunoexpression of TS, p53, COX2, EGFR, MSH6 and MLH1 biomarkers and its correlation with degree of differentiation, tumor staging and prognostic factors in colorectal adenocarcinoma: a retrospective longitudinal study.
Batista WR; Santos G; Vital FMR; Matos D
Sao Paulo Med J; 2019 May; 137(1):33-38. PubMed ID: 31116268
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization of thymidylate synthase as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.
Takagi K; Miki Y; Nakamura Y; Hirakawa H; Kakugawa Y; Amano G; Watanabe M; Ishida T; Sasano H; Suzuki T
Histol Histopathol; 2015 Oct; 30(10):1223-32. PubMed ID: 25873048
[TBL] [Abstract][Full Text] [Related]
20. New prognostic indicator for non-small-cell lung cancer, quantitation of thymidylate synthase by real-time reverse transcription polymerase chain reaction.
Shintani Y; Ohta M; Hirabayashi H; Tanaka H; Iuchi K; Nakagawa K; Maeda H; Kido T; Miyoshi S; Matsuda H
Int J Cancer; 2003 May; 104(6):790-5. PubMed ID: 12640689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]